type here...

CATEGORIES

Cancers

LATEST

1...8910...18Page 9 of 18

TRENDING

EDITORS CHOICE

Artificial Intelligence, Microbiome, and Predicting Liver Disease

Michael Hunter, MD -
Increasing evidence suggests an interplay between the gut microbiome and nonalcoholic fatty liver disease (NAFLD). The role of the microbiome in the early detection of the condition remains unclear.

Quitting Alcohol Drops Your Cancer Risk, Right? Not So Fast.

Michael Hunter, MD -
THERE IS NOT STRONG EVIDENCE TO PROVE THAT CUTTING DOWN (or completely stopping) alcohol intake will significantly reduce the risk of most cancers. Yes, I, too,...

Promise and Peril of Instant Health Information Access for Consumers

Gil Bashe, Medika Life Editor -
Apps and AI Help Patients Access in a Blink Their Diagnostic Data: But Lacking Physician Input Fuels Fear

Addressing Global Income Disparities in Acute Lymphoblastic Leukaemia Care

Christopher Nial -
he stark disparity in the diagnosis and treatment of Acute Lymphoblastic Leukaemia (ALL) between high-income countries (HICs) and low- and middle-income countries (LMICs) highlights a critical issue in global healthcare equity.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories